The prognostic value of the depth of response in multiple myeloma depends on the time of assessment, risk status and molecular subtype

• Carolina Schinke,
• Antje Hoering,
• Hongwei Wang,
• Victoria Carlton,
• Sharmilan Thanandrarajan,
• Shayu Deshpande,
• Purvi Patel,
• Gabor Molnar,
• Sandra Susanibar,
• Meera Mohan,
• Pankaj Mathur,
• Muthukumar Radhakrishnan,
• Shadiqul Hoque,
• Jorge Jo Kamimoto,
• Monica Grazziutti,
• Frits van Rhee,
• Maurizio Zangari,
• Giovanni Insuasti-Beltran,
• Daisy Alapat,
• Ginell Post,
• Shmuel Yaccoby,
• Joshua Epstein,
• Leo Rasche,
• Sarah Johnson,
• Martin Moorhead,
• Tom Willis,
• Bart Barlogie,
• Brian Walker,
• Niels Weinhold,
• Faith E Davies,
• Gareth J. Morgan

Affiliations

Carolina Schinke

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Antje Hoering

Cancer Resarch and Biostatistics, Seattle, WA, USA

Hongwei Wang

Cancer Resarch and Biostatistics, Seattle, WA, USA

Victoria Carlton

Adaptive Biotechnologies, San Francisco, CA, USA

Sharmilan Thanandrarajan

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Shayu Deshpande

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Purvi Patel

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Gabor Molnar

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Sandra Susanibar

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Meera Mohan

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Pankaj Mathur

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Muthukumar Radhakrishnan

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Shadiqul Hoque

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Jorge Jo Kamimoto

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Monica Grazziutti

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Frits van Rhee

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Maurizio Zangari

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Giovanni Insuasti-Beltran

Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Daisy Alapat

Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Ginell Post

Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Shmuel Yaccoby

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Joshua Epstein

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Leo Rasche

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Sarah Johnson

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Martin Moorhead

Adaptive Biotechnologies, San Francisco, CA, USA

Tom Willis

Adaptive Biotechnologies, San Francisco, CA, USA

Bart Barlogie

Mt. Sinai School of Medicine, New York, NY, USA

Brian Walker

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Niels Weinhold

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Faith E Davies

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA

Gareth J. Morgan

Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA